An Endocrinology Clinic in Dyslipidemia

Case 1: A Patient With Diabetes

Case 2: More Advanced Disease in a Patient With Diabetes

Prevalence of Chronic Conditions in T2D

Causes of Death Among Patients With Type 2 Diabetes

Prevention of CVD in T2D: CARDS Trial

Treatment of Dyslipidemia in Diabetes

Statin LDL-C Lowering Efficacy

Lipid Effects of Drug Classes in Dyslipidemia

ACCORD: Statin + Fenofibrate in T2D

AIM-HIGH: Statin + Niacin

Ezetimibe in Patient with Diabetes

Safety of Very Low LDL-C Levels: Insights From the JUPITER Trial

ODYSSEY LONG-TERM Adverse Events in Patients With 2 Consecutive LDL-C < 25 mg/dL

LDL-C Lowering in Diabetes

Safety of PCSK9 Inhibitors in T2D

Abbreviations

Abbreviations (cont)

Abbreviations (cont)